Transcription of Chapter 8: Screening for cervical cancer in developing ...
{{id}} {{{paragraph}}}
Vaccine 24S3 (2006) S3/71 S3/77 Chapter 8: Screening for cervical cancer in developing countriesLynette Dennya, , Michael Quinnb, R. SankaranarayanancaGroote Schuur Hospital, University of Cape Town, H45 Old Main Building, Observatory 7925, Cape Town, South AfricabUniversity Department of Obstetrics and Gynaecology and Oncology/Dysplasia Unit, Royal Women s Hospital, Melbourne, AustraliacScreening Group, International Agency for Research on cancer , Lyon, FranceReceived 14 March 2006; accepted 31 May 2006 AbstractOrganised and quality assured cytology-based Screening programmes have substantially reduced cervical cancer incidence in many devel-oped countries. However, there are considerable barriers to setting up cytology-based Screening programs, particularly in developing has stimulated the search for novel and alternative approaches to cytology for cervical cancer prevention. These approaches generallyperform as well as cytology, and sometimes better, although many of them have a lower specificity, resulting in higher false-positive rates.
S3/72 L. Denny et al. / Vaccine 24S3 (2006) S3/71–S3/77 facilities for screening or treatment [2]. Malawi, for instance, which has a cervical cancer incidence rate of 47 per 10,000 women, has one pathologist, one colposcope, no cytotech-
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}